{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:20:21Z","timestamp":1793748021529,"version":"4.6.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["201809-2016862"],"award-info":[{"award-number":["201809-2016862"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["JPND2021-00694"],"award-info":[{"award-number":["JPND2021-00694"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["UKDRI-1003"],"award-info":[{"award-number":["UKDRI-1003"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["02905\/EC 643417"],"award-info":[{"award-number":["02905\/EC 643417"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["643417"],"award-info":[{"award-number":["643417"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["860197"],"award-info":[{"award-number":["860197"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007436","name":"Erling-Perssons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2022-01018"],"award-info":[{"award-number":["2022-01018"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2019-02397"],"award-info":[{"award-number":["2019-02397"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2023-00356"],"award-info":[{"award-number":["2023-00356"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001858","name":"Sweden's Innovation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021720","name":"Olav Thon Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021720","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jpet.2025.103400","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T19:11:39Z","timestamp":1739387499000},"page":"103400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["\u03b3-Secretase modulation inhibits amyloid plaque formation and growth and stimulates plaque regression in amyloid precursor protein\/presenilin-1 mice"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1811-2823","authenticated-orcid":false,"given":"Gunnar","family":"Nordvall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3816-7474","authenticated-orcid":false,"given":"Lotta","family":"Agholme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Lundkvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8385-456X","authenticated-orcid":false,"given":"Johan","family":"Sandin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2097-7658","authenticated-orcid":false,"given":"Henrik","family":"Biverst\u00e5l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Winblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecka","family":"Klintenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Ferm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Cirrito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Moo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2025.103400_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41598-019-57143-x","article-title":"High-yield production of amyloid-\u03b2 peptide enabled by a customized spider silk domain","volume":"10","author":"Abelein","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2025.103400_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/srep29200","article-title":"Amyloid precursor protein expression and processing are differentially regulated during cortical neuron differentiation","volume":"6","author":"Bergstr\u00f6m","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2025.103400_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13195-016-0199-5","article-title":"Characterization of FRM-36143 as a new \u03b3-secretase modulator for the potential treatment of familial Alzheimer\u2019s disease","volume":"8","author":"Blain","year":"2016","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"10.1016\/j.jpet.2025.103400_bib4","doi-asserted-by":"crossref","first-page":"11810","DOI":"10.1074\/jbc.M111.305227","article-title":"First and second generation \u03b3-secretase modulators (GSMs) modulate amyloid-\u03b2 (A\u03b2) peptide production through different mechanisms","volume":"287","author":"Borgegard","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jpet.2025.103400_bib5","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1039\/D1SC02990H","article-title":"Amyloid-\u03b2peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-\u03b2 42 aggregation\u2020","volume":"13","author":"Braun","year":"2022","journal-title":"Chem Sci"},{"key":"10.1016\/j.jpet.2025.103400_bib42","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1172\/JCI23269","article-title":"Anti-abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice","volume":"115","author":"Brendza","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpet.2025.103400_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/alz.060772","article-title":"Higher CSF Ab38 levels protect against cognitive decline in high-functioning individuals","volume":"18","author":"Bruno","year":"2022","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.jpet.2025.103400_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.semcdb.2020.03.005","article-title":"Mechanisms of neurodegeneration\u2014Insights from familial Alzheimer\u2019s disease","volume":"105","author":"Ch\u00e1vez-Guti\u00e9rrez","year":"2020","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.jpet.2025.103400_bib40","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1523\/JNEUROSCI.21-03-00858.2001","article-title":"Growth arrest of individual senile plaques inn a model of Alzheimer\u2019s disease observed by in vivo multiphoton microscopy. J","volume":"21","author":"Christie","year":"2001","journal-title":"Neurosci"},{"key":"10.1016\/j.jpet.2025.103400_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2008.02.003","article-title":"Endocytosis is required for synaptic activity-dependent release of amyloid-\u03b2 in\u00a0vivo","volume":"58","author":"Cirrito","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.jpet.2025.103400_bib9","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1523\/JNEUROSCI.23-26-08844.2003","article-title":"In\u00a0vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-\u03b2 metabolism and half-life","volume":"23","author":"Cirrito","year":"2003","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jpet.2025.103400_bib10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","article-title":"Synaptic activity regulates interstitial fluid amyloid-\u03b2 levels in\u00a0vivo","volume":"48","author":"Cirrito","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.jpet.2025.103400_bib11","doi-asserted-by":"crossref","first-page":"e958","DOI":"10.1212\/WNL.0000000000013228","article-title":"Association of CSF A\u03b238 levels with risk of Alzheimer disease\u2013related decline","volume":"98","author":"Cullen","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.jpet.2025.103400_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"Dyck","year":"2022","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jpet.2025.103400_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-4-19","article-title":"Existing plaques and neuritic abnormalities in APP:PS1 mice are not affected by administration of the gamma-secretase inhibitor LY-411575","volume":"4","author":"Garcia-Alloza","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.jpet.2025.103400_bib14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jpet.2025.103400_bib15","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1185\/03007995.2014.939167","article-title":"Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings","volume":"30","author":"Henley","year":"2014","journal-title":"Curr M\u00e9d Res Opin"},{"key":"10.1016\/j.jpet.2025.103400_bib16","doi-asserted-by":"crossref","first-page":"10673","DOI":"10.1073\/pnas.0700148104","article-title":"Acute stress increases interstitial fluid amyloid-\u03b2 via corticotropin-releasing factor and neuronal activity","volume":"104","author":"Kang","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jpet.2025.103400_bib39","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/jnen\/61.9.797","article-title":"Imaging A\u03b2 plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative","volume":"61","author":"Klunk","year":"2002","journal-title":"J Neuropat Exp Neurol"},{"key":"10.1016\/j.jpet.2025.103400_bib17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/mp.2013.122","article-title":"Chronic \u03b3-secretase inhibition reduces amyloid plaque-associated instability of pre- and postsynaptic structures","volume":"19","author":"Liebscher","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jpet.2025.103400_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/toxsci\/kfh254","article-title":"Modulation of notch processing by \u03b3-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation","volume":"82","author":"Milano","year":"2004","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jpet.2025.103400_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1084\/jem.20170600","article-title":"Short A\u03b2 peptides attenuate A\u03b242 toxicity in\u00a0vivo","volume":"215","author":"Moore","year":"2018","journal-title":"J\u00a0Exp Medicine"},{"key":"10.1016\/j.jpet.2025.103400_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac267","article-title":"Neurons derived from individual early Alzheimer\u2019s disease patients reflect their clinical vulnerability","volume":"4","author":"Ng","year":"2022","journal-title":"Brain Commun"},{"key":"10.1016\/j.jpet.2025.103400_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1279740","article-title":"Gamma-secretase modulators: a promising route for the treatment of Alzheimer\u2019s disease","volume":"16","author":"Nordvall","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.jpet.2025.103400_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.celrep.2012.11.028","article-title":"\u03b3-secretase modulators and presenilin 1 mutants act differently on presenilin\/\u03b3-secretase function to cleave A\u03b242 and A\u03b243","volume":"3","author":"Okochi","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.jpet.2025.103400_bib37","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1074\/jbc.M113.498246","article-title":"Characterization of intermediate steps in amyloid beta (A\u03b2) production under near-native conditions","volume":"289","author":"Olsson","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpet.2025.103400_bib22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00401-017-1804-9","article-title":"BACE1 inhibition more effectively suppresses initiation than progression of \u03b2-amyloid pathology","volume":"135","author":"Peters","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jpet.2025.103400_bib23","first-page":"1","article-title":"A\u03b2 profiles generated by Alzheimer\u2019s disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset","author":"Petit","year":"2022","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.jpet.2025.103400_bib24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00401-010-0690-1","article-title":"Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer\u2019s disease","volume":"120","author":"Portelius","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jpet.2025.103400_bib25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41598-020-80164-w","article-title":"The A\u03b2(1\u201338) peptide is a negative regulator of the A\u03b2(1\u201342) peptide implicated in Alzheimer disease progression","volume":"11","author":"Quartey","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2025.103400_bib26","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.nbd.2004.10.022","article-title":"Episodic-like memory deficits in the APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease: relationships to \u03b2-amyloid deposition and neurotransmitter abnormalities","volume":"18","author":"Savonenko","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jpet.2025.103400_bib27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1474-4422(24)00236-9","article-title":"\u03b3-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer\u2019s disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)","volume":"23","author":"Schultz","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jpet.2025.103400_bib28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer\u2019s disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.jpet.2025.103400_bib29","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/nprot.2012.116","article-title":"Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks","volume":"7","author":"Shi","year":"2012","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jpet.2025.103400_bib30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jpet.2025.103400_bib31","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1093\/hmg\/ddv246","article-title":"Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10\u00a0+ 16 splice-site mutation in MAPT","volume":"24","author":"Sposito","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jpet.2025.103400_bib32","first-page":"1","article-title":"New precision medicine avenues to the prevention of Alzheimer\u2019s disease from insights into the structure and function of \u03b3-secretases","author":"Strooper","year":"2024","journal-title":"EMBO J"},{"key":"10.1016\/j.jpet.2025.103400_bib33","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.cell.2021.03.058","article-title":"Alzheimer\u2019s-causing mutations shift A\u03b2 length by destabilizing \u03b3-secretase-A\u03b2n interactions","volume":"184","author":"Szaruga","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jpet.2025.103400_bib41","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nn1335","article-title":"Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches","volume":"7","author":"Tsai","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jpet.2025.103400_bib34","doi-asserted-by":"crossref","first-page":"32640","DOI":"10.1074\/jbc.M112.376541","article-title":"Second generation \u03b3-secretase modulators exhibit different modulation of notch \u03b2 and A\u03b2 production","volume":"287","author":"Wanngren","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jpet.2025.103400_bib35","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/alz.12164","article-title":"Cognitive outcomes in trials of two BACE inhibitors in Alzheimer\u2019s disease","volume":"16","author":"Wessels","year":"2020","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.jpet.2025.103400_bib36","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1523\/JNEUROSCI.2637-09.2009","article-title":"Characterizing the appearance and growth of amyloid plaques in APP\/PS1 mice","volume":"29","author":"Yan","year":"2009","journal-title":"J\u00a0Neurosci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525396138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525396138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:32:28Z","timestamp":1762209148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525396138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0022356525396138"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103400","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b3-Secretase modulation inhibits amyloid plaque formation and growth and stimulates plaque regression in amyloid precursor protein\/presenilin-1 mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"103400"}}